BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27154489)

  • 1. Survival After Heart Transplantation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    DePasquale EC; Cheng RK; Deng MC; Nsair A; McKenna WJ; Fonarow GC; Jacoby DL
    J Card Fail; 2017 Feb; 23(2):107-112. PubMed ID: 27154489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart transplantation outcomes in arrhythmogenic right ventricular cardiomyopathy: a contemporary national analysis.
    Giuliano K; Scheel P; Etchill E; Fraser CD; Suarez-Pierre A; Hsu S; Wittstein IS; Kasper EK; Florido R; Tandri H; Calkins H; Choi CW; Sharma K; Kilic A; Gilotra NA
    ESC Heart Fail; 2022 Apr; 9(2):988-997. PubMed ID: 35132806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart transplantation in arrhythmogenic right ventricular cardiomyopathy - Experience from the Nordic ARVC Registry.
    Gilljam T; Haugaa KH; Jensen HK; Svensson A; Bundgaard H; Hansen J; Dellgren G; Gustafsson F; Eiskjær H; Andreassen AK; Sjögren J; Edvardsen T; Holst AG; Svendsen JH; Platonov PG
    Int J Cardiol; 2018 Jan; 250():201-206. PubMed ID: 29107359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experience.
    Scheel PJ; Giuliano K; Tichnell C; James C; Murray B; Tandri H; Carter D; Fehr T; Umapathi P; Vaishnav J; Lewsey SC; Hsu S; Calkins H; Sharma K; Choi CW; Gilotra NA; Kilic A
    ESC Heart Fail; 2022 Apr; 9(2):1008-1017. PubMed ID: 34953065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Utility of Cardiopulmonary Exercise Testing in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia.
    Scheel PJ; Florido R; Hsu S; Murray B; Tichnell C; James CA; Agafonova J; Tandri H; Judge DP; Russell SD; Tedford RJ; Calkins H; Gilotra NA
    J Am Heart Assoc; 2020 Feb; 9(3):e013695. PubMed ID: 32009524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Presentation and Outcomes by Sex in Arrhythmogenic Right Ventricular Cardiomyopathy: Findings from the North American ARVC Registry.
    Choudhary N; Tompkins C; Polonsky B; McNitt S; Calkins H; Mark Estes NA; Krahn AD; Link MS; Marcus FI; Towbin JA; Zareba W
    J Cardiovasc Electrophysiol; 2016 May; 27(5):555-62. PubMed ID: 26840461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different prognostic value of functional right ventricular parameters in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Saguner AM; Vecchiati A; Baldinger SH; Rüeger S; Medeiros-Domingo A; Mueller-Burri AS; Haegeli LM; Biaggi P; Manka R; Lüscher TF; Fontaine G; Delacrétaz E; Jenni R; Held L; Brunckhorst C; Duru F; Tanner FC
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):230-9. PubMed ID: 24515411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry.
    Pinamonti B; Dragos AM; Pyxaras SA; Merlo M; Pivetta A; Barbati G; Di Lenarda A; Morgera T; Mestroni L; Sinagra G
    Eur Heart J; 2011 May; 32(9):1105-13. PubMed ID: 21362707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa.
    Watkins DA; Hendricks N; Shaboodien G; Mbele M; Parker M; Vezi BZ; Latib A; Chin A; Little F; Badri M; Moolman-Smook JC; Okreglicki A; Mayosi BM;
    Heart Rhythm; 2009 Nov; 6(11 Suppl):S10-7. PubMed ID: 19880068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Differences in Japanese Patients Between Brugada Syndrome and Arrhythmogenic Right Ventricular Cardiomyopathy With Long-Term Follow-Up.
    Kataoka N; Nagase S; Kamakura T; Nakajima K; Wada M; Yamagata K; Ishibashi K; Inoue YY; Miyamoto K; Noda T; Aiba T; Izumi C; Noguchi T; Yasuda S; Kamakura S; Kusano K
    Am J Cardiol; 2019 Sep; 124(5):715-722. PubMed ID: 31284935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex Differences in Mortality Based on United Network for Organ Sharing Status While Awaiting Heart Transplantation.
    Hsich EM; Blackstone EH; Thuita L; McNamara DM; Rogers JG; Ishwaran H; Schold JD
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy.
    Dechering DG; Kochhäuser S; Wasmer K; Zellerhoff S; Pott C; Köbe J; Spieker T; Piers SR; Bittner A; Mönnig G; Breithardt G; Wichter T; Zeppenfeld K; Eckardt L
    Heart Rhythm; 2013 Feb; 10(2):158-64. PubMed ID: 23070261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of ventricular assist devices on post-transplant mortality an analysis of the United network for organ sharing thoracic registry.
    Patlolla V; Patten RD; Denofrio D; Konstam MA; Krishnamani R
    J Am Coll Cardiol; 2009 Jan; 53(3):264-71. PubMed ID: 19147043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can abnormal dispersion of ventricular repolarization be a predictor of mortality in arrhythmogenic right ventricular cardiomyopathy: The importance of Tp-e interval.
    Cekirdekci EI; Bugan B
    Ann Noninvasive Electrocardiol; 2019 May; 24(3):e12619. PubMed ID: 30412321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes and risk factors for heart transplantation in children with end-stage cardiomyopathy†.
    Alsoufi B; Kanter K; McCracken C; Kogon B; Vincent R; Mahle W; Deshpande S
    Eur J Cardiothorac Surg; 2016 Jan; 49(1):85-92. PubMed ID: 25724907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ventricular ectopic QRS interval (VEQSI): Diagnosis of arrhythmogenic right ventricular cardiomyopathy in patients with incomplete disease expression.
    Bastiaenen R; Pantazis A; Gonna H; Chis-Ster I; Castelletti S; Batchvarov VN; Domenichini G; Coccolo F; Boriani G; McKenna WJ; Behr ER; Gallagher MM
    Heart Rhythm; 2016 Jul; 13(7):1504-12. PubMed ID: 27016477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy.
    Maron MS; Kalsmith BM; Udelson JE; Li W; DeNofrio D
    Circ Heart Fail; 2010 Sep; 3(5):574-9. PubMed ID: 20736440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentation.
    Bhonsale A; Te Riele ASJM; Sawant AC; Groeneweg JA; James CA; Murray B; Tichnell C; Mast TP; van der Pols MJ; Cramer MJM; Dooijes D; van der Heijden JF; Tandri H; van Tintelen JP; Judge DP; Hauer RNW; Calkins H
    Heart Rhythm; 2017 Jun; 14(6):883-891. PubMed ID: 28215569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D): Review of 16 Pediatric Cases and a Proposal of Modified Pediatric Criteria.
    Deshpande SR; Herman HK; Quigley PC; Shinnick JK; Cundiff CA; Caltharp S; Shehata BM
    Pediatr Cardiol; 2016 Apr; 37(4):646-55. PubMed ID: 26743400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of left ventricular dilation at listing for heart transplant with postlisting and early posttransplant mortality in children with dilated cardiomyopathy.
    Singh TP; Sleeper LA; Lipshultz S; Cinar A; Canter C; Webber SA; Bernstein D; Pahl E; Alvarez JA; Wilkinson JD; Towbin JA; Colan SD
    Circ Heart Fail; 2009 Nov; 2(6):591-8. PubMed ID: 19919984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.